Rhenman & Partners Asset Management Ab Merck & Co., Inc. Transaction History
Rhenman & Partners Asset Management Ab
- $840 Million
- Q1 2025
A detailed history of Rhenman & Partners Asset Management Ab transactions in Merck & Co., Inc. stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 33,000 shares of MRK stock, worth $2.56 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
33,000
Previous 277,500
88.11%
Holding current value
$2.56 Million
Previous $27.6 Million
89.27%
% of portfolio
0.35%
Previous 2.88%
Shares
22 transactions
Others Institutions Holding MRK
# of Institutions
3,891Shares Held
1.93BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA253MShares$19.6 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.1 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.35 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.34 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$4.63 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $197B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...